TNFSF10 and neoplasm: Because the detached cells were found to be more sensitive to TRAIL, circulating tumour cells (CTCs) were considered as a potential target for TRAIL therapy.134 In fact, DR4/DR5 signalling allows caspase activation, leading to cleavage of Akt proteins and to their decreased expression levels.